Study of Stress Hyperglycemia as an Indicator of Diabetes Mellitus

N/ATerminatedNCT02068989

Yale University1 enrolled

Overview

We hypothesize that stress hyperglycemia is an indicator that a patient will develop type 2 diabetes mellitus in the future. Subjects who are not diabetic are enrolled and blood glucose readings reviewed during their intensive care unit stay. All subjects are consented and have a HbA1C level drawn to determine if they have diabetes mellitus or not. They are then followed up in 1 year and the HbA1C repeated to determine if they have developed diabetes mellitus over the course.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Stress Hyperglycemia Diabetes Mellitus Type 2

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * All patients admitted to the intensive care unit at the Yale New Haven Hospital St. Raphael Campus and Norwalk Hospital Exclusion Criteria: * Patients with prior history of diabetes mellitus * Elevated admission HbA1c (≥6.5%) * Age \>80 years * Metastatic disease with expected life expectancy of less than 12 months * Pregnancy or a woman who plans to become pregnant

Locations (2)

Yale New Haven Hospital St. Raphael Campus

New Haven, Connecticut, United States

Norwalk Hospital

Norwalk, Connecticut, United States

Outcomes

Primary Outcomes

Percentage of Subjects with an HbA1c greater than or equal to 6.5%

Time frame: 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.